Recent Finacing
Recent Raise
Notify Therapeutics develops a non-hormonal, NRF2-pathway modulating drug to activate ovarian follicles and promote egg maturation, targeting diminished ovarian reserve with preclinical validation in mice and human ovarian tissue.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
